UBS GROUP AG-REG (0UB.DE) Fundamental Analysis & Valuation

FRA:0UB • CH0244767585

Current stock price

33.69 EUR
-0.65 (-1.89%)
Last:

This 0UB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. 0UB.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 0UB was profitable.
  • In the past year 0UB had a positive cash flow from operations.
  • In the past 5 years 0UB has always been profitable.
  • In the past 5 years 0UB always reported a positive cash flow from operatings.
0UB.DE Yearly Net Income VS EBIT VS OCF VS FCF0UB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B -40B 60B 80B

1.2 Ratios

  • 0UB's Return On Assets of 0.48% is in line compared to the rest of the industry. 0UB outperforms 46.49% of its industry peers.
  • 0UB has a Return On Equity (8.61%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.48%
ROE 8.61%
ROIC N/A
ROA(3y)0.8%
ROA(5y)0.75%
ROE(3y)15.52%
ROE(5y)14.45%
ROIC(3y)N/A
ROIC(5y)N/A
0UB.DE Yearly ROA, ROE, ROIC0UB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • 0UB has a Profit Margin (14.87%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of 0UB has declined.
  • The Operating Margin and Gross Margin are not available for 0UB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 14.87%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.92%
PM growth 5Y-4.6%
GM growth 3YN/A
GM growth 5YN/A
0UB.DE Yearly Profit, Operating, Gross Margins0UB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. 0UB.DE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for 0UB has been reduced compared to 1 year ago.
  • The number of shares outstanding for 0UB has been reduced compared to 5 years ago.
  • The debt/assets ratio for 0UB has been reduced compared to a year ago.
0UB.DE Yearly Shares Outstanding0UB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
0UB.DE Yearly Total Debt VS Total Assets0UB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T

2.2 Solvency

  • The Debt to FCF ratio of 0UB is 18.83, which is on the high side as it means it would take 0UB, 18.83 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 18.83, 0UB is doing good in the industry, outperforming 64.04% of the companies in the same industry.
  • A Debt/Equity ratio of 4.06 is on the high side and indicates that 0UB has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 4.06, 0UB is doing worse than 62.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 18.83
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
0UB.DE Yearly LT Debt VS Equity VS FCF0UB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
0UB.DE Yearly Current Assets VS Current Liabilites0UB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. 0UB.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.26% over the past year.
  • 0UB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.80% yearly.
  • The Revenue has been growing slightly by 2.03% in the past year.
  • The Revenue has been growing by 8.43% on average over the past years. This is quite good.
EPS 1Y (TTM)55.26%
EPS 3Y1.75%
EPS 5Y5.8%
EPS Q2Q%60.87%
Revenue 1Y (TTM)2.03%
Revenue growth 3Y12.93%
Revenue growth 5Y8.43%
Sales Q2Q%4.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.17% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.74% on average over the next years.
EPS Next Y42.76%
EPS Next 2Y32.72%
EPS Next 3Y26.63%
EPS Next 5Y22.17%
Revenue Next Year5.88%
Revenue Next 2Y4.42%
Revenue Next 3Y4.19%
Revenue Next 5Y3.74%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
0UB.DE Yearly Revenue VS Estimates0UB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
0UB.DE Yearly EPS VS Estimates0UB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. 0UB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.43 indicates a correct valuation of 0UB.
  • Based on the Price/Earnings ratio, 0UB is valued a bit cheaper than 65.79% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.21. 0UB is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 11.52, the valuation of 0UB can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, 0UB is valued cheaper than 82.46% of the companies in the same industry.
  • 0UB is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.43
Fwd PE 11.52
0UB.DE Price Earnings VS Forward Price Earnings0UB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 92.11% of the companies in the same industry are more expensive than 0UB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.66
EV/EBITDA N/A
0UB.DE Per share data0UB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 0UB's earnings are expected to grow with 26.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)2.83
EPS Next 2Y32.72%
EPS Next 3Y26.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 0UB.DE Dividend Analysis

5.1 Amount

  • 0UB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

0UB.DE Fundamentals: All Metrics, Ratios and Statistics

UBS GROUP AG-REG

FRA:0UB (4/7/2026, 7:00:00 PM)

33.69

-0.65 (-1.89%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners58.99%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap112.58B
Revenue(TTM)52.24B
Net Income(TTM)7.77B
Analysts76.92
Price Target42.01 (24.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.79
Dividend Growth(5Y)4.69%
DP36.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.41%
Min EPS beat(2)-31.52%
Max EPS beat(2)40.34%
EPS beat(4)1
Avg EPS beat(4)0.7%
Min EPS beat(4)-31.52%
Max EPS beat(4)40.34%
EPS beat(8)4
Avg EPS beat(8)13.76%
EPS beat(12)4
Avg EPS beat(12)-36.35%
EPS beat(16)8
Avg EPS beat(16)-21.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.36%
Revenue beat(4)0
Avg Revenue beat(4)-3.33%
Min Revenue beat(4)-5.19%
Max Revenue beat(4)-1.36%
Revenue beat(8)3
Avg Revenue beat(8)1.06%
Revenue beat(12)7
Avg Revenue beat(12)3.06%
Revenue beat(16)11
Avg Revenue beat(16)3.57%
PT rev (1m)0%
PT rev (3m)12.17%
EPS NQ rev (1m)3.6%
EPS NQ rev (3m)1.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.71%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)7.99%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE 16.43
Fwd PE 11.52
P/S 2.48
P/FCF 6.66
P/OCF 5.94
P/B 1.44
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)2.05
EY6.08%
EPS(NY)2.92
Fwd EY8.68%
FCF(TTM)5.06
FCFY15.02%
OCF(TTM)5.67
OCFY16.84%
SpS13.57
BVpS23.42
TBVpS21.62
PEG (NY)0.38
PEG (5Y)2.83
Graham Number32.87
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 8.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.87%
GM N/A
FCFM 37.31%
ROA(3y)0.8%
ROA(5y)0.75%
ROE(3y)15.52%
ROE(5y)14.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.92%
PM growth 5Y-4.6%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 18.83
Debt/EBITDA N/A
Cap/Depr 66.93%
Cap/Sales 4.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 250.92%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)54.91%
Cap/Depr(5y)66.36%
Cap/Sales(3y)4.12%
Cap/Sales(5y)4.36%
Profit Quality(3y)194.76%
Profit Quality(5y)230.29%
High Growth Momentum
Growth
EPS 1Y (TTM)55.26%
EPS 3Y1.75%
EPS 5Y5.8%
EPS Q2Q%60.87%
EPS Next Y42.76%
EPS Next 2Y32.72%
EPS Next 3Y26.63%
EPS Next 5Y22.17%
Revenue 1Y (TTM)2.03%
Revenue growth 3Y12.93%
Revenue growth 5Y8.43%
Sales Q2Q%4.38%
Revenue Next Year5.88%
Revenue Next 2Y4.42%
Revenue Next 3Y4.19%
Revenue Next 5Y3.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.41%
EBIT Next 3Y21.5%
EBIT Next 5YN/A
FCF growth 1Y1433.36%
FCF growth 3Y14.44%
FCF growth 5Y-11.1%
OCF growth 1Y566.39%
OCF growth 3Y14.26%
OCF growth 5Y-9.98%

UBS GROUP AG-REG / 0UB.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UBS GROUP AG-REG (0UB.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 0UB.DE.


Can you provide the valuation status for UBS GROUP AG-REG?

ChartMill assigns a valuation rating of 6 / 10 to UBS GROUP AG-REG (0UB.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for UBS GROUP AG-REG?

UBS GROUP AG-REG (0UB.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for 0UB stock?

The Earnings per Share (EPS) of UBS GROUP AG-REG (0UB.DE) is expected to grow by 42.76% in the next year.


How sustainable is the dividend of UBS GROUP AG-REG (0UB.DE) stock?

The dividend rating of UBS GROUP AG-REG (0UB.DE) is 0 / 10 and the dividend payout ratio is 36.9%.